Company Valuation: Elliptic Laboratories ASA

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 2,882 2,295 1,786 1,103 714.9 339.8 - -
Change - -20.36% -22.15% -38.24% -35.2% -52.46% - -
Enterprise Value (EV) 1 2,681 2,129 1,697 1,046 671.8 272.8 289 296.8
Change - -20.57% -20.32% -38.34% -35.79% -59.39% 5.93% 2.7%
P/E -252x -71.1x -47.3x 116x -5.14x -10.9x -54.5x 56.9x
PBR 8.41x 7.04x 5.82x 3.39x 3.8x 1.6x 1.6x 1.52x
PEG - -0x -2.9x -1x 0x 0.1x 0.7x -0x
Capitalization / Revenue 45.7x 44.1x 26.1x 8.36x 6.96x 3.33x 2.8x 2.25x
EV / Revenue 42.5x 40.9x 24.8x 7.93x 6.54x 2.67x 2.38x 1.96x
EV / EBITDA -948x -69.1x -50.6x 41.7x -32.5x -46.1x 16.5x 8.21x
EV / EBIT -241x -50.5x -34.1x 222x -14.8x -8.66x -32.9x 37.3x
EV / FCF -94.3x -59x - - -29.1x -10.9x -28.9x -297x
FCF Yield -1.06% -1.69% - - -3.44% -9.16% -3.46% -0.34%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -0.11 -0.31 -0.36 0.09 -1.32 -0.2475 -0.0494 0.0473
Distribution rate - - - - - - - -
Net sales 1 63.04 52.06 68.32 131.9 102.7 102.2 121.3 151.3
EBITDA 1 -2.829 -30.81 -33.52 25.12 -20.68 -5.917 17.56 36.17
EBIT 1 -11.14 -42.13 -49.74 4.71 -45.44 -31.5 -8.792 7.947
Net income 1 -11.16 -32.04 -37.85 8.96 -139 -32.05 -6.465 6.262
Net Debt 1 -201 -165.5 -89.72 -57.04 -43.06 -67.03 -50.86 -43.07
Reference price 2 27.750 22.050 17.040 10.480 6.790 2.690 2.690 2.690
Nbr of stocks (in thousands) 103,842 104,074 104,838 105,275 105,287 126,337 - -
Announcement Date 10/03/22 17/02/23 15/02/24 27/02/25 26/02/26 - - -
1NOK in Million2NOK
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-10.87x2.67x-46.11x-.--% 35.14M
-355.26x6.71x25.06x-.--% 24.59B
154.52x0.86x10.91x-.--% 7.42B
14.93x - - - 4.59B
60.45x1.51x10.87x-.--% 3.51B
21.61x - - - 433M
-11.02x - - - 375M
Average -17.95x 2.94x 0.18x 0% 5.85B
Weighted average by Cap. -178.34x 4.97x 20.64x 0%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. ELABS Stock
  4. Valuation Elliptic Laboratories ASA